BLOG
Read the blog
Protocol Design Concepts in Phase I Ethnobridging Clinical Trials
In Phase I ethnobridging clinical trials, there are three primary protocol design concepts utilized. These concepts align the strategy with global clinical development and measure key factors necessary for meeting the unique needs of the Sponsor.
SELECT A CATEGORY BELOW
-
Blog
Prioritizing the Compassionate Care of Research Animals
The 3Rs philosophy is the guiding principle for the Animal Welfare Program at Altasciences.
-
-
Blog
2020 Year in Review
2020 has been quite a year! Each year, we strive to provide you with a more innovative, simplified, and seamless early phase drug development journey. And the past 12 months have been no exception.
-
Blog
Clinical Applications of Hallucinogens, Dissociatives and other Schedule I Drugs
Hallucinogens, dissociatives and other Schedule I drugs are increasingly being found to have a clinical application in a number of therapeutic areas. Recent approvals, background, and related case studies in this month's blog.
-
Blog
Improving Solubility of Molecules via Nano Milling
The formulation of an active pharmaceutical ingredient (API) to ensure maximum bioavailability is central to successful drug development. When an API is insoluble or poorly soluble, it will require processing...
-
Blog
Rigorous Sample Handling Processes
Ensuring that current and relevant FDA and EMA guidances are applied to the handling of bioanalytical samples during clinical trial conduct is crucial. This month's blog, including podcast, offers an expert look at the considerations.
-
Blog
From Lead Candidate to In-life Use
The development of pharmaceutical products, in dosage forms that the human body can safely and effectively metabolize, is a challenging undertaking. In this month's blog, we offer insight on the process, and a related podcast featuring our CDMO experts.
